PRESS RELEASE published on 02/05/2025 at 07:00, 1 year 1 month ago Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ® Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF published on 12/05/2024 at 07:35, 1 year 3 months ago Valneva Reports Share and Voting Rights as of November 30, 2024 Euronext Paris Share Capital Voting Rights Valneva Double Voting
BRIEF published on 12/05/2024 at 07:35, 1 year 3 months ago Valneva publie ses actions et ses droits de vote au 30 novembre 2024 Euronext Paris Capital Social Droit De Vote Valneva Double Vote
PRESS RELEASE published on 12/05/2024 at 07:30, 1 year 3 months ago VALNEVA - Declaration of shares and voting rights: November 30, 2024 VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727 Euronext Paris Voting Rights Shares Stock Market Valneva
PRESS RELEASE published on 12/05/2024 at 07:30, 1 year 3 months ago Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024 Déclaration d'actions et de droits de vote de VALNEVA pour le 30 novembre 2024 incluant les variations telles que le passage au porteur et en droit de vote double Droits De Vote Actions Valneva Variation Porteur
BRIEF published on 12/04/2024 at 10:02, 1 year 3 months ago Polar Capital réduit sa participation dans VALNEVA SE Droits De Vote Franchissement De Seuil Actions Valneva SE Polar Capital
BRIEF published on 12/04/2024 at 10:02, 1 year 3 months ago Polar Capital reduces its stake in VALNEVA SE Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
PRESS RELEASE published on 12/04/2024 at 09:57, 1 year 3 months ago Franchissement de seuil Déclaration de franchissement de seuil par Polar Capital LLP pour compte de fonds, détenant 4,92% du capital de VALNEVA SE Déclaration Franchissement De Seuil Valneva SE Fonds Polar Capital LLP
BRIEF published on 12/04/2024 at 07:05, 1 year 3 months ago Valneva Publishes Findings on Chikungunya Impact in British Medical Journal Climate Change Chikungunya Health Impact Economic Burden Global Study
BRIEF published on 12/04/2024 at 07:05, 1 year 3 months ago Valneva publie ses résultats sur l'impact du chikungunya dans le British Medical Journal Changement Climatique Chikungunya Impact Sur La Santé Fardeau Économique Étude Mondiale
Published on 03/23/2026 at 11:30, 27 minutes ago Trans Canada Gold Provides Update on Non-Brokered Private Placement and Flow-through Private Placement for Drilling at the Harrison Lake District Scale Gold Property Acquisition
Published on 03/23/2026 at 08:00, 3 hours 57 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 9 hours 57 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 11:44, 12 minutes ago Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Published on 03/23/2026 at 11:30, 27 minutes ago EQS Group lance un module de gestion des risques pour faciliter la surveillance continue des risques liées aux données et à l’IA
Published on 03/23/2026 at 11:06, 50 minutes ago Aroundtown SA: Release of a capital market information
Published on 03/23/2026 at 11:05, 51 minutes ago ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 52 minutes ago BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Published on 03/23/2026 at 08:10, 3 hours 47 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
